TrialCardiovascular diabetology2023

An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteria.

Peter Bramlage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.